-+ 0.00%
-+ 0.00%
-+ 0.00%

*Merck: 3Q Januvia/Janumet Sales Fell Primarily Driven by Lower Demand Due to Generic Competition Following Loss of Market Exclusivity in U.S. >MRK

Dow Jones·10/29/2026 10:34:02